1. Home
  2. SLRX vs IVP Comparison

SLRX vs IVP Comparison

Compare SLRX & IVP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLRX
  • IVP
  • Stock Information
  • Founded
  • SLRX N/A
  • IVP 2020
  • Country
  • SLRX United States
  • IVP United States
  • Employees
  • SLRX N/A
  • IVP N/A
  • Industry
  • SLRX Biotechnology: Pharmaceutical Preparations
  • IVP Diversified Commercial Services
  • Sector
  • SLRX Health Care
  • IVP Miscellaneous
  • Exchange
  • SLRX Nasdaq
  • IVP Nasdaq
  • Market Cap
  • SLRX 3.6M
  • IVP 3.4M
  • IPO Year
  • SLRX N/A
  • IVP 2023
  • Fundamental
  • Price
  • SLRX $4.18
  • IVP N/A
  • Analyst Decision
  • SLRX
  • IVP
  • Analyst Count
  • SLRX 0
  • IVP 0
  • Target Price
  • SLRX N/A
  • IVP N/A
  • AVG Volume (30 Days)
  • SLRX 316.4K
  • IVP 165.6K
  • Earning Date
  • SLRX 11-13-2025
  • IVP 11-12-2025
  • Dividend Yield
  • SLRX N/A
  • IVP N/A
  • EPS Growth
  • SLRX N/A
  • IVP N/A
  • EPS
  • SLRX N/A
  • IVP N/A
  • Revenue
  • SLRX N/A
  • IVP $15,292,904.00
  • Revenue This Year
  • SLRX N/A
  • IVP N/A
  • Revenue Next Year
  • SLRX N/A
  • IVP N/A
  • P/E Ratio
  • SLRX N/A
  • IVP N/A
  • Revenue Growth
  • SLRX N/A
  • IVP N/A
  • 52 Week Low
  • SLRX $3.64
  • IVP $0.63
  • 52 Week High
  • SLRX $108.00
  • IVP $24.61
  • Technical
  • Relative Strength Index (RSI)
  • SLRX 50.63
  • IVP 51.45
  • Support Level
  • SLRX $3.86
  • IVP $0.93
  • Resistance Level
  • SLRX $4.58
  • IVP $1.00
  • Average True Range (ATR)
  • SLRX 0.37
  • IVP 0.07
  • MACD
  • SLRX -0.14
  • IVP -0.01
  • Stochastic Oscillator
  • SLRX 45.45
  • IVP 27.83

About SLRX Salarius Pharmaceuticals Inc.

Salarius Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing effective treatments for cancers with high, unmet medical needs. The company has focused on two classes of drugs that address gene dysregulation: targeted protein inhibitors and targeted protein degradation. Its Pipeline includes seclidemstat (SP-2577), a small molecular inhibitor, and SP-3164, a small molecular protein degrader.

About IVP Inspire Veterinary Partners Inc.

Inspire Veterinary Partners Inc owns and operates veterinary hospitals throughout the United States. The company specializes in small animal general practice hospitals that serve all manner of companion pets, emphasizing canine and feline breeds.

Share on Social Networks: